These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
360 related articles for article (PubMed ID: 30198517)
1. A Prognostic Nomogram for Disease-Specific Survival in Patients with Pancreatic Ductal Adenocarcinoma of the Head of the Pancreas Following Pancreaticoduodenectomy. Li HB; Zhou J; Zhao FQ Med Sci Monit; 2018 Sep; 24():6313-6321. PubMed ID: 30198517 [TBL] [Abstract][Full Text] [Related]
2. A nomogram based on preoperative inflammatory markers predicting the overall survival of pancreatic ductal adenocarcinoma. Xu J; Shi KQ; Chen BC; Huang ZP; Lu FY; Zhou MT J Gastroenterol Hepatol; 2017 Jul; 32(7):1394-1402. PubMed ID: 27973703 [TBL] [Abstract][Full Text] [Related]
3. Prognostic Nomogram for patients undergoing radical Pancreaticoduodenectomy for adenocarcinoma of the pancreatic head. Wu C; Hou SZ; Wu Z; Huang X; Wang Z; Tian B BMC Cancer; 2021 May; 21(1):624. PubMed ID: 34044806 [TBL] [Abstract][Full Text] [Related]
4. Development and validation of novel nomograms for predicting the survival of patients after surgical resection of pancreatic ductal adenocarcinoma. Li G; Chen JZ; Chen S; Lin SZ; Pan W; Meng ZW; Cai XR; Chen YL Cancer Med; 2020 May; 9(10):3353-3370. PubMed ID: 32181599 [TBL] [Abstract][Full Text] [Related]
5. Pancreaticoduodenectomy is justified in a subset of elderly patients with pancreatic ductal adenocarcinoma: A population-based retrospective cohort study of 4,283 patients. Lu L; Zhang X; Tang G; Shang Y; Liu P; Wei Y; Gong P; Ma L Int J Surg; 2018 May; 53():262-268. PubMed ID: 29604352 [TBL] [Abstract][Full Text] [Related]
6. Pancreatic volume is one of the independent prognostic factors for resectable pancreatic ductal adenocarcinomas. Fukumoto T; Watanabe T; Hirai I; Kimura W J Hepatobiliary Pancreat Sci; 2016 Aug; 23(8):472-9. PubMed ID: 27246905 [TBL] [Abstract][Full Text] [Related]
7. Prognostic Nomogram for Disease-Specific Survival in Patients with Non-metastatic Ampullary Carcinoma After Surgery. Li HB; Zhao FQ; Zhou J Ann Surg Oncol; 2019 Apr; 26(4):1079-1085. PubMed ID: 30659390 [TBL] [Abstract][Full Text] [Related]
8. Preoperative serum C-reactive protein levels and post-operative lymph node ratio are important predictors of survival after pancreaticoduodenectomy for pancreatic ductal adenocarcinoma. Sanjay P; de Figueiredo RS; Leaver H; Ogston S; Kulli C; Polignano FM; Tait IS JOP; 2012 Mar; 13(2):199-204. PubMed ID: 22406601 [TBL] [Abstract][Full Text] [Related]
9. Superior Mesenteric Artery Margin of Posttherapy Pancreaticoduodenectomy and Prognosis in Patients With Pancreatic Ductal Adenocarcinoma. Liu L; Katz MH; Lee SM; Fischer LK; Prakash L; Parker N; Wang H; Varadhachary GR; Wolff RA; Lee JE; Pisters PW; Maitra A; Fleming JB; Estrella J; Rashid A; Wang H Am J Surg Pathol; 2015 Oct; 39(10):1395-403. PubMed ID: 26200098 [TBL] [Abstract][Full Text] [Related]
10. A case-matched comparison study of total pancreatectomy versus pancreaticoduodenectomy for patients with pancreatic ductal adenocarcinoma. Xiong J; Wei A; Ke N; He D; Chian SK; Wei Y; Hu W; Liu X Int J Surg; 2017 Dec; 48():134-141. PubMed ID: 29081373 [TBL] [Abstract][Full Text] [Related]
11. Nomogram for predicting the survival of gastric adenocarcinoma patients who receive surgery and chemotherapy. Wang CY; Yang J; Zi H; Zheng ZL; Li BH; Wang Y; Ge Z; Jian GX; Lyu J; Li XD; Ren XQ BMC Cancer; 2020 Jan; 20(1):10. PubMed ID: 31906882 [TBL] [Abstract][Full Text] [Related]
12. The prognostic influence of intrapancreatic tumor location on survival after resection of pancreatic ductal adenocarcinoma. Ruess DA; Makowiec F; Chikhladze S; Sick O; Riediger H; Hopt UT; Wittel UA BMC Surg; 2015 Nov; 15():123. PubMed ID: 26615588 [TBL] [Abstract][Full Text] [Related]
13. A model to predict survival following pancreaticoduodenectomy for malignancy based on tumour site, stage and lymph node ratio. Dasari BV; Roberts KJ; Hodson J; Stevens L; Smith AM; Hubscher SG; Isaac J; Muiesan P; Sutcliffe RP; Marudanayagam R; Mirza DF HPB (Oxford); 2016 Apr; 18(4):332-8. PubMed ID: 27037202 [TBL] [Abstract][Full Text] [Related]
14. Survival after pancreaticoduodenectomy for periampullary adenocarcinoma: an update. van Geenen RC; van Gulik TM; Offerhaus GJ; de Wit LT; Busch OR; Obertop H; Gouma DJ Eur J Surg Oncol; 2001 Sep; 27(6):549-57. PubMed ID: 11520088 [TBL] [Abstract][Full Text] [Related]
16. The Results of Pancreatic Resections and Long-Term Survival for Pancreatic Ductal Adenocarcinoma: A Single-Institution Experience. Seppänen H; Juuti A; Mustonen H; Haapamäki C; Nordling S; Carpelan-Holmström M; Sirén J; Luettges J; Haglund C; Kiviluoto T Scand J Surg; 2017 Mar; 106(1):54-61. PubMed ID: 27130378 [TBL] [Abstract][Full Text] [Related]
17. Metastatic lymph node ratio as an important prognostic factor in pancreatic ductal adenocarcinoma. Robinson SM; Rahman A; Haugk B; French JJ; Manas DM; Jaques BC; Charnley RM; White SA Eur J Surg Oncol; 2012 Apr; 38(4):333-9. PubMed ID: 22317758 [TBL] [Abstract][Full Text] [Related]
18. Nomogram to predict overall survival and disease-specific survival with appendiceal mucinous adenocarcinoma. Yan Q; Zheng WJ; Chen QL; Wang BQ; Luo HY; Xue J; Wang XW Medicine (Baltimore); 2019 Oct; 98(40):e17332. PubMed ID: 31577727 [TBL] [Abstract][Full Text] [Related]
19. [A result of surgical treatment for ductal adenocarcinoma of the head of the pancreas]. Moon HJ; Jang KT; Heo JS; Choi SH; Joh JW; Kim YI Korean J Gastroenterol; 2003 Aug; 42(2):156-63. PubMed ID: 14532721 [TBL] [Abstract][Full Text] [Related]
20. Pancreatic fibrosis, acinar atrophy and chronic inflammation in surgical specimens associated with survival in patients with resectable pancreatic ductal adenocarcinoma. Korpela T; Ristimäki A; Udd M; Vuorela T; Mustonen H; Haglund C; Kylänpää L; Seppänen H BMC Cancer; 2022 Jan; 22(1):23. PubMed ID: 34980011 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]